… , Acinetobacter baumannii, Pseudomonas aeruginosa, and … baumannii infections, there is
mounting pressure to find new … While A.baumannii remains a major public health challenge …

… identification in less than 40% of patients with clinically diagnosed IVACs [12]. This has
traditionally made challenging … ; (b) to appropriately place novel antimicrobial agents in lack of …

… baumannii, with the objective of identifying the most … that effectively escape the effects
of antibacterial drugs [16]. … such as Pseudomonas aeruginosa, Acinetobacter baumannii, …

… Multidrug resistance to antibiotics is a challenging global … , Pseudomonas aeruginosa,
Acinetobacter baumannii) present … initial attributes of an antibacterial agent effective against Gram-…

… To develop new efficacious antimicrobial agents, it is necessary to know the pathways …
mechanisms of virulence and antibacterial resistance is crucial to identify new biological targets. …

… Bacterial biofilms still remain a challenge to the healthcare system due to their resilience
against antimicrobial agents and immune system. Moreover, mechanisms involved in biofilm …

… It is intrinsically resistant to many antimicrobial agents and additional acquired … to
ceftolozane-tazobactam has been identified in P. … aeruginosa, in challenging clinical situations …

… Finally, new antimicrobial agents such as eravacycline and … of this challenging pathogen,
antimicrobial resistant AB (MDR, DTR, … Enterobacteriaceae and Pseudomonas aeruginosa and …

… antimicrobial agents used to treat A baumannii and P aeruginosa infections in this country. …
A central laboratory verified identification of the isolates and performed susceptibility testing …

… to identify microorganisms and evaluate susceptibility to the following … challenge.
Cephalosporins and quinolones have long been extensively administered as the empirical treatment …